Login / Signup

Refining colorectal cancer classification and clinical stratification through a single-cell atlas.

Ateeq M KhaliqCihat ErdoganZeyneb KurtSultan Sevgi TurgutMiles W GrunvaldTim RandSonal KhareJeffrey A BorgiaDana M HaydenSam G PappasHenry R GovekarAudrey E KamJochen ReiserKiran TuragaMilan RadovichYong ZangYingjie QiuYunlong LiuMelissa L FishelAnita TurkVineet GuptaRam Al-SabtiJanakiraman SubramanianTimothy M KuzelAnguraj SadanandamLevi WaldronArif HussainMohammad SaleemBassel El-RayesAmeen A SalahudeenAshiq Masood
Published in: Genome biology (2022)
Distinct CAFs and C1Q+ TAMs are sufficient to explain CMS predictive ability and a simpler signature based on these cellular phenotypes could stratify CRC patient prognosis with greater precision. Therapeutically targeting specific CAF subtypes and C1Q + TAMs may promote immunotherapy responses in CRC patients.
Keyphrases
  • single cell
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • rna seq
  • machine learning
  • deep learning
  • prognostic factors
  • patient reported outcomes